Literature DB >> 15720369

Characterizing the ADHD phenotype for genetic studies.

Jim Stevenson1, Phil Asherson, David Hay, Florence Levy, Jim Swanson, Anita Thapar, Erik Willcutt.   

Abstract

The genetic study of ADHD has made considerable progress. Further developments in the field will be reliant in part on identifying the most appropriate phenotypes for genetic analysis. The use of both categorical and dimensional measures of symptoms related to ADHD has been productive. The use of multiple reporters is a valuable feature of the characterization of psychopathology in children. It is argued that the use of aggregated measures to characterize the ADHD phenotype, particularly to establish its pervasiveness, is desirable. The recognition of the multiple comorbidities of ADHD can help to isolate more specific genetic influences. In relation to both reading disability and conduct disorder there is evidence that genes may be involved in the comorbid condition that are different from pure ADHD. To date, progress with the investigation of endophenotypes for ADHD has been disappointing. It is suggested that extending such studies beyond cognitive underpinnings to include physiological and metabolic markers might facilitate progress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15720369     DOI: 10.1111/j.1467-7687.2005.00398.x

Source DB:  PubMed          Journal:  Dev Sci        ISSN: 1363-755X


  14 in total

1.  Does attention-deficit/hyperactivity disorder have a dimensional latent structure? A taxometric analysis.

Authors:  David K Marcus; Tammy D Barry
Journal:  J Abnorm Psychol       Date:  2011-05

2.  The Co-Occurrence of Autism Spectrum Disorder in Children With ADHD.

Authors:  Benjamin Zablotsky; Matthew D Bramlett; Stephen J Blumberg
Journal:  J Atten Disord       Date:  2017-06-14       Impact factor: 3.256

3.  Moderator effects of working memory on the stability of ADHD symptoms by dopamine receptor gene polymorphisms during development.

Authors:  Joey W Trampush; Michelle M Jacobs; Yasmin L Hurd; Jeffrey H Newcorn; Jeffrey M Halperin
Journal:  Dev Sci       Date:  2014-01-11

4.  Exploring how symptoms of attention-deficit/hyperactivity disorder are related to reading and mathematics performance: general genes, general environments.

Authors:  Sara A Hart; Stephen A Petrill; Erik Willcutt; Lee A Thompson; Christopher Schatschneider; Kirby Deater-Deckard; Laurie E Cutting
Journal:  Psychol Sci       Date:  2010-10-21

Review 5.  Molecular genetics of attention deficit hyperactivity disorder.

Authors:  Stephen V Faraone; Eric Mick
Journal:  Psychiatr Clin North Am       Date:  2010-03

6.  The SWAN captures variance at the negative and positive ends of the ADHD symptom dimension.

Authors:  Anne B Arnett; Bruce F Pennington; Angela Friend; Erik G Willcutt; Brian Byrne; Stefan Samuelsson; Richard K Olson
Journal:  J Atten Disord       Date:  2011-12-15       Impact factor: 3.256

7.  Latent Class Analysis of ADHD Neurodevelopmental and Mental Health Comorbidities.

Authors:  Benjamin Zablotsky; Matthew D Bramlett; Susanna N Visser; Melissa L Danielson; Stephen J Blumberg
Journal:  J Dev Behav Pediatr       Date:  2018-01       Impact factor: 2.225

8.  Perinatal and familial risk factors are associated with full syndrome and subthreshold attention-deficit hyperactivity disorder in a korean community sample.

Authors:  Hyo-Won Kim; Soo-Churl Cho; Boong-Nyun Kim; Jae-Won Kim; Min-Sup Shin; Yeni Kim
Journal:  Psychiatry Investig       Date:  2009-11-05       Impact factor: 2.505

Review 9.  Comorbidity of internalizing disorders in children with oppositional defiant disorder.

Authors:  Khrista Boylan; Tracy Vaillancourt; Michael Boyle; Peter Szatmari
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-24       Impact factor: 4.785

10.  Gently restless: association of ADHD-like traits with response inhibition and interference control.

Authors:  Bertalan Polner; Désirée Aichert; Christine Macare; Anna Costa; Ulrich Ettinger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-11       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.